Journal
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
Volume 74, Issue 2, Pages 384-404Publisher
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/01635581.2021.1884730
Keywords
-
Categories
Funding
- Instituto Tecnologico Metropolitano
- Colciencias grant [115080763215 CT 811-2018]
Ask authors/readers for more resources
In recent years, dietary polyphenols have garnered interest as potentially anti-carcinogenic compounds by modulating the Wnt/beta-Catenin signaling pathway to reduce the risk of colorectal cancer. Promising results from clinical trials suggest the potential implementation of these dietary polyphenols into preventative and therapeutic therapies for CRC.
In the last few decades there has been a rise in the worldwide incidence of colorectal cancer which can be traced back to the influence of well-known modifiable risk factors such as lifestyle, diet and obesity. Conversely, the consumption of fruits, vegetables and fiber decreases the risk of CRC, which is why dietary polyphenols have aroused interest in recent years as potentially anti-carcinogenic compounds. One of the driving forces of colorectal carcinogenesis, in both sporadic and hereditary CRC, is the aberrant activation/regulation of the Wnt/beta-catenin pathway. This review discusses reports of modulation of the Wnt/beta-Catenin signaling pathway by dietary polyphenols (resveratrol, avenanthramides, epigallocatechinin, curcumin, quercetin, silibinin, genistein and mangiferin) specifically focusing on CRC, and proposes a model as to how this modulation occurs. There is potential for implementing these dietary polyphenols into preventative and therapeutic therapies for CRC as evidenced by some clinical trials that have been carried out with promising results.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available